Aspire BioPharma, Inc.

New Filing
CIK: 0001995528·Pharmaceuticals·PUERTO RICO·Filed: Nov 1, 2023
Total Offering

$10,000,000

Amount Sold

$0

Investors

0

First Sale

N/A

Offering Details

Type
Equity
Exemptions
Rule 506(c)
Entity Type
Corporation
Year Incorporated
2021
Non-Accredited Investors
No

Related Persons

NameRole
Edward Kimball
Related Person
Rodrick Prat
Related Person
Stephen Quesenberry
Related Person
Kraig Higginson
Related Person
Ernest scheidemann
Related Person

Company

Aspire BioPharma, Inc.

194 CANDELERO DRIVE, #223

HUMACAO, PR, 00797

801-427-1111

SEC Filing

0001493152-23-038912

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Aspire BioPharma, Inc. Form D Filing — $10,000,000 | FilingFlow